Designer GLP1 poly-agonist peptides in the management of diabesity
{{output}}
Introduction: To date, the 21st Century has witnessed key developments in the management of diabesity (a conflation of obesity and Type 2 Diabetes Mellitus [T2D]), including Glucagon Like Peptide 1 (GLP1) receptor agonist therapi... ...
